KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Non Operating Income (2017 - 2025)

Ionis Pharmaceuticals has reported Non Operating Income over the past 9 years, most recently at -$1.0 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$1.0 million for Q4 2025, down 446.69% from a year ago — trailing twelve months through Dec 2025 was -$117000.0 (down 108.79% YoY), and the annual figure for FY2025 was -$118000.0, down 108.87%.
  • Non Operating Income for Q4 2025 was -$1.0 million at Ionis Pharmaceuticals, down from $363000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for IONS hit a ceiling of $11.2 million in Q2 2023 and a floor of -$12.3 million in Q2 2022.
  • Median Non Operating Income over the past 5 years was $257500.0 (2023), compared with a mean of $435400.0.
  • Peak annual rise in Non Operating Income hit 15610.0% in 2021, while the deepest fall reached 5816.78% in 2021.
  • Ionis Pharmaceuticals' Non Operating Income stood at $9.4 million in 2021, then plummeted by 93.11% to $649000.0 in 2022, then plummeted by 63.33% to $238000.0 in 2023, then grew by 26.89% to $302000.0 in 2024, then tumbled by 446.69% to -$1.0 million in 2025.
  • The last three reported values for Non Operating Income were -$1.0 million (Q4 2025), $363000.0 (Q3 2025), and $102000.0 (Q2 2025) per Business Quant data.